ask="2.40"
ask_size="500"
average_daily_volume="720836"
bid="2.00"
bid_size="200"
book_value="0.32"
change="-0.11"
change_from_200_day_moving_average="0.54"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-0.36"
change_From_52_week_low="1.42"
change_in_percent="-5.00%"
close="2.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.17"
ebitda="-24.62M"
eps_estimate_current_year="-0.17"
eps_estimate_next_quarter="-0.04"
eps_estimate_next_year="-0.10"
ex_dividend_date="N/A"
float_shares="116398000"
high="2.23"
high_52_weeks="2.45"
last_trade_date="1/13/2017"
last_trade_price="2.09"
last_trade_size="4917"
last_trade_time="4:00pm"
low="2.04"
low_52_weeks="0.67"
market_capitalization="324.13M"
moving_average_200_day="1.55"
moving_average_50_day="2.13"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="3.63"
open="2.20"
pe_ratio="N/A"
peg_ratio="-0.16"
percent_change_from_200_day_moving_average="+34.56%"
percent_change_from_50_day_moving_average="-2.03%"
percent_change_from_52_week_high="-14.69%"
percent_change_from_52_week_low="+211.94%"
previous_close="2.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.96"
price_per_sales="6.85"
revenue="49.83M"
shares_outstanding="155086000"
short_ratio="4.04"
stock_exchange="NCM"
symbol="ATRS"
volume="1905790"
weeks_range_52="0.67 - 2.45"
